• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群在糖尿病视网膜病变中作用的最新见解

Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy.

作者信息

Jiao Jinghua, Yu Honghua, Yao Litong, Li Lihua, Yang Xiaohong, Liu Lei

机构信息

Department of Anesthesiology, Central Hospital, Shenyang Medical College, Shenyang, Liaoning, 110024, People's Republic of China.

Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510120, People's Republic of China.

出版信息

J Inflamm Res. 2021 Dec 16;14:6929-6938. doi: 10.2147/JIR.S336148. eCollection 2021.

DOI:10.2147/JIR.S336148
PMID:34938095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8687677/
Abstract

The microbiome has become a hot issue in recent years. The composition, modification, alteration, and disturbance of gut microbiota were found to influence important physiological processes, including energy metabolism and microenvironmental homeostasis, and lead to various diseases, including obesity, type 2 diabetes mellitus and chronic kidney disease. Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus and one of the leading causes of blindness and vision impairment. The underlying mechanisms in DR pathogenesis remain limited. Recently, important insights have been made regarding possible connections between gut microbiome dysbiosis and ocular disease including DR, uveitis, glaucoma, and age-related macular degeneration, and the concept of a "microbiota-gut-retina axis" has been put forward. Hence, we reviewed current understanding of the relationship between DR and gut microbiota. We summarized potential pathophysiological mechanisms that contribute to the role of the gut microbiota on DR, including hyperglycemia, anti-diabetes drugs, microbial metabolites, and inflammatory properties. We aimed to find novel effective therapeutic options to prevent the onset and development of DR.

摘要

近年来,微生物组已成为一个热门话题。研究发现,肠道微生物群的组成、修饰、改变和紊乱会影响包括能量代谢和微环境稳态在内的重要生理过程,并导致各种疾病,包括肥胖、2型糖尿病和慢性肾脏病。糖尿病视网膜病变(DR)是糖尿病的一种主要微血管并发症,也是失明和视力损害的主要原因之一。DR发病机制的潜在机制仍然有限。最近,关于肠道微生物群失调与包括DR、葡萄膜炎、青光眼和年龄相关性黄斑变性在内的眼部疾病之间可能存在的联系,人们有了重要的认识,并提出了“微生物群-肠道-视网膜轴”的概念。因此,我们综述了目前对DR与肠道微生物群之间关系的理解。我们总结了肠道微生物群在DR中发挥作用的潜在病理生理机制,包括高血糖、抗糖尿病药物、微生物代谢产物和炎症特性。我们旨在寻找预防DR发生和发展的新型有效治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c316/8687677/2efdf645ea04/JIR-14-6929-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c316/8687677/2efdf645ea04/JIR-14-6929-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c316/8687677/2efdf645ea04/JIR-14-6929-g0001.jpg

相似文献

1
Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy.肠道微生物群在糖尿病视网膜病变中作用的最新见解
J Inflamm Res. 2021 Dec 16;14:6929-6938. doi: 10.2147/JIR.S336148. eCollection 2021.
2
Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies.肠道微生物群和代谢物在糖尿病视网膜病变中的作用:对新型治疗策略发病机制的深入了解。
Biomed Pharmacother. 2023 Aug;164:114994. doi: 10.1016/j.biopha.2023.114994. Epub 2023 Jun 8.
3
The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy.肠-视网膜轴:糖尿病视网膜病变防治的新视角。
Front Endocrinol (Lausanne). 2023 Jul 4;14:1205846. doi: 10.3389/fendo.2023.1205846. eCollection 2023.
4
The Role of Microbiota in Retinal Disease.微生物群在视网膜疾病中的作用。
Adv Exp Med Biol. 2018;1074:429-435. doi: 10.1007/978-3-319-75402-4_53.
5
Gut Microbiota Dysbiosis in Diabetic Retinopathy-Current Knowledge and Future Therapeutic Targets.糖尿病视网膜病变中的肠道微生物群失调——当前认知与未来治疗靶点
Life (Basel). 2023 Apr 7;13(4):968. doi: 10.3390/life13040968.
6
Gut microbiota: A potential therapeutic target for management of diabetic retinopathy?肠道微生物群:糖尿病视网膜病变管理的潜在治疗靶点?
Life Sci. 2021 Dec 1;286:120060. doi: 10.1016/j.lfs.2021.120060. Epub 2021 Oct 16.
7
Evidence Suggesting the Role of Gut Dysbiosis in Diabetic Retinopathy.证据表明肠道菌群失调在糖尿病视网膜病变中的作用。
Invest Ophthalmol Vis Sci. 2022 Jul 8;63(8):21. doi: 10.1167/iovs.63.8.21.
8
The gut microbiota in retinal diseases.视网膜疾病中的肠道微生物群。
Exp Eye Res. 2022 Jan;214:108867. doi: 10.1016/j.exer.2021.108867. Epub 2021 Nov 29.
9
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy.肠道微生物群失调及其在糖尿病视网膜病变中的意义
Front Cell Infect Microbiol. 2021 Mar 19;11:646348. doi: 10.3389/fcimb.2021.646348. eCollection 2021.
10
From Gut to Eye: Exploring the Role of Microbiome Imbalance in Ocular Diseases.从肠道到眼睛:探索微生物群失衡在眼部疾病中的作用。
J Clin Med. 2024 Sep 21;13(18):5611. doi: 10.3390/jcm13185611.

引用本文的文献

1
The role of gut microbiota dysbiosis in the inflammatory pathogenesis of diabetic retinopathy.肠道微生物群失调在糖尿病视网膜病变炎症发病机制中的作用。
Front Immunol. 2025 Jul 7;16:1604315. doi: 10.3389/fimmu.2025.1604315. eCollection 2025.
2
The causal impact of gut microbiota and metabolites on myopia and pathological myopia: a mediation Mendelian randomization study.肠道微生物群和代谢产物对近视和病理性近视的因果影响:一项中介孟德尔随机化研究。
Sci Rep. 2025 Apr 15;15(1):12928. doi: 10.1038/s41598-025-97722-9.
3
The Relationship Between Gut Microbiome and Ophthalmologic Diseases: A Comprehensive Review.

本文引用的文献

1
Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus.利拉鲁肽对2型糖尿病患者肠道微生物群的结构调节作用
PeerJ. 2021 Apr 1;9:e11128. doi: 10.7717/peerj.11128. eCollection 2021.
2
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy.肠道微生物群失调及其在糖尿病视网膜病变中的意义
Front Cell Infect Microbiol. 2021 Mar 19;11:646348. doi: 10.3389/fcimb.2021.646348. eCollection 2021.
3
Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy.
肠道微生物群与眼科疾病的关系:综述
Cureus. 2024 Aug 13;16(8):e66808. doi: 10.7759/cureus.66808. eCollection 2024 Aug.
4
Mendelian randomization analysis reveals a causal effect of Streptococcus salivarius on diabetic retinopathy through regulating host fasting glucose.孟德尔随机化分析揭示了唾液链球菌通过调节宿主空腹血糖对糖尿病视网膜病变的因果影响。
J Cell Mol Med. 2024 Apr;28(7):e18200. doi: 10.1111/jcmm.18200.
5
Research progress on the pathogenesis of diabetic retinopathy.糖尿病视网膜病变发病机制的研究进展。
BMC Ophthalmol. 2023 Sep 11;23(1):372. doi: 10.1186/s12886-023-03118-6.
6
Gut microbiota and eye diseases: a bibliometric study and visualization analysis.肠道微生物群与眼部疾病:文献计量学研究与可视化分析。
Front Cell Infect Microbiol. 2023 Aug 9;13:1225859. doi: 10.3389/fcimb.2023.1225859. eCollection 2023.
7
The Link Between Gastrointestinal Microbiome and Ocular Disorders.胃肠道微生物群与眼部疾病之间的联系
Clin Ophthalmol. 2023 Jul 25;17:2133-2140. doi: 10.2147/OPTH.S415425. eCollection 2023.
8
The effects of fermented feedstuff derived from Citri Sarcodactylis Fructus by-products on growth performance, intestinal digestive enzyme activity, nutrient utilization, meat quality, gut microbiota, and metabolites of broiler chicken.由佛手柑副产品制成的发酵饲料对肉鸡生长性能、肠道消化酶活性、养分利用率、肉质、肠道微生物群和代谢产物的影响。
Front Vet Sci. 2023 Jul 4;10:1231996. doi: 10.3389/fvets.2023.1231996. eCollection 2023.
9
The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy.肠-视网膜轴:糖尿病视网膜病变防治的新视角。
Front Endocrinol (Lausanne). 2023 Jul 4;14:1205846. doi: 10.3389/fendo.2023.1205846. eCollection 2023.
10
Gut Microbiota Dysbiosis in Diabetic Retinopathy-Current Knowledge and Future Therapeutic Targets.糖尿病视网膜病变中的肠道微生物群失调——当前认知与未来治疗靶点
Life (Basel). 2023 Apr 7;13(4):968. doi: 10.3390/life13040968.
2 型糖尿病合并糖尿病视网膜病变患者肠道细菌微生物组的改变。
Sci Rep. 2021 Feb 2;11(1):2738. doi: 10.1038/s41598-021-82538-0.
4
Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems.醛糖还原酶和施万细胞中的多元醇途径:旧问题和新问题。
Int J Mol Sci. 2021 Jan 21;22(3):1031. doi: 10.3390/ijms22031031.
5
Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.补充姜黄素能否降低血液透析患者肠道源性尿毒症毒素的血浆水平?一项前瞻性随机双盲对照研究。
Int Urol Nephrol. 2021 Jun;53(6):1231-1238. doi: 10.1007/s11255-020-02760-z. Epub 2021 Jan 12.
6
Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease.合生素可减轻慢性肾脏病患者的肠道吲哚负荷和肠道菌群失调。
Cells. 2021 Jan 9;10(1):114. doi: 10.3390/cells10010114.
7
Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial.粪便微生物群移植在随机对照试验中阻止了人类新发 1 型糖尿病的进展。
Gut. 2021 Jan;70(1):92-105. doi: 10.1136/gutjnl-2020-322630. Epub 2020 Oct 26.
8
Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice.钠-葡萄糖共转运蛋白 2 抑制剂可降低糖尿病小鼠中的琥珀酸水平。
World J Gastroenterol. 2020 Jun 21;26(23):3225-3235. doi: 10.3748/wjg.v26.i23.3225.
9
Concentrations of Selected Cytokines and Vascular Endothelial Growth Factor in Aqueous Humor and Serum of Diabetic Patients.糖尿病患者房水和血清中特定细胞因子及血管内皮生长因子的浓度
Semin Ophthalmol. 2020 Feb 17;35(2):126-133. doi: 10.1080/08820538.2020.1755320. Epub 2020 Apr 20.
10
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice.黄连素对高脂饮食喂养的ApoE-/-小鼠动脉粥样硬化及肠道菌群调节的影响及其相关性
Front Pharmacol. 2020 Mar 13;11:223. doi: 10.3389/fphar.2020.00223. eCollection 2020.